HDFC Securities is bullish on Alembic Pharma has recommended buy rating on the stock with a target price of Rs 635 in its research report dated July 20, 2017.

Hold Alembic Pharmaceuticals; target of Rs 610: Axis Direct

Axis Direct recommended hold rating on Alembic Pharmaceuticals with a target price of Rs 610 in its research report dated May 09, 2017.

Hold Alembic Pharma; target of Rs 615: ICICI Direct

ICICI Direct recommended hold rating on Alembic Pharma with a target price of Rs 615 in its research report dated January 30, 2017.

Accumulate Alembic Pharma; target of Rs 667: KR Choksey

KR Choksey has recommended accumulate rating on Alembic Pharma with a target price of Rs 667 in its research report dated January 27, 2017.

Buy Alembic Pharmaceuticals; target of Rs 808: GEPL Capital

GEPL Capital is bullish on Alembic Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 808 in its research report dated October 19, 2016.

Hold Alembic Pharmaceuticals; target of Rs 700: Axis Direct

Axis Direct recommended hold rating on Alembic Pharmaceuticals with a target price of Rs 700 in its research report dated October 26, 2016.

Buy Alembic Pharma; target of Rs 728: Anand Rathi

Anand Rathi is bullish on Alembic Pharma has recommended buy rating on the stock with a target price of Rs 728 in its research report dated September 30, 2016.

Hold Alembic Pharma; target of Rs 620: ICICI Direct

ICICI Direct has recommended hold rating on Alembic Pharma with a target price of Rs 620 in its research report dated August 02, 2016.

Hold Alembic Pharma; target of Rs 600: Axis Direct

Axis Direct has recommended hold rating on Alembic Pharma with a target price of Rs 600 in its research report dated August 01, 2016.

Hold Alembic Pharma; target of Rs 640: KR Choksey

KR Choksey recommended hold rating on Alembic Pharma with a target price of Rs 640 in its research report dated August 01, 2016.

Hold Alembic Pharma; target of Rs 600: Axis Direct

Axis Direct recommended hold rating on Alembic Pharma with a target price of Rs 600 in its research report dated July 05, 2016.

Hold Alembic Pharma; target of Rs 576: Anand Rathi

Anand Rathi recommended hold rating on Alembic Pharma with a target price of Rs 576 in its research report dated June 30, 2016.

Sell Alembic Pharma; target of Rs 560: Axis Securities

Axis Securities is bearish on Alembic Pharma has recommended reduce rating on the stock with a target price of Rs 560 in its research report dated April 28, 2016.

Hold Alembic Pharma; target of Rs 623: KRChoksey

KRChoksey has recommended hold rating on Alembic Pharma with a target price of Rs 623 in its research report dated April 28, 2016.

Buy Alembic Pharma; target of Rs 790:ICICIDirect

ICICIDirect is bullish on Alembic Pharma and has recommended buy rating on the stock with a target price of Rs 790 in its research report dated January 21, 2016.

Sell Alembic Pharma; target of Rs 560: Axis Securities

Axis Securities is bearish on Alembic Pharma and has recommended sell rating on the stock with a target price of Rs 560 in its research report dated January 22, 2016.

Buy Alembic Pharma; target of Rs 756; KRChoksey

KRChoksey is bullish on Alembic Pharma and has recommended 'Accumulate' rating on the stock with a target price of Rs 756 in its research report dated October 28, 2015

Here are SP Tulsian's top trading ideas

Watch the interview of technical analyst, SP Tulsian of sptulsian.com with Latha Venkatesh and Sonia Shenoy of CNBC-TV18. He shared his reading and outlook on the market and also gave recommendations on various stocks.

Accumulate Alembic Pharma; target of Rs 756:KRChoksey

KRChoksey is bullish on Alembic Pharmaceuticals and has recommended accumulate rating on the stock with a target price of Rs 756 in its research report dated October 28, 2015

Buy Alembic Pharma; target Rs 790: ICICIdirect

ICICIdirect.com is bullish on Alembic Pharma and has recommended buy rating on the stock with a target price of Rs 790, in its research report dated September 28, 2015.

Hold Alembic Pharma; target of Rs 700: KRChoksey

Brokerage house KRChoksey has recommended a hold rating on Alembic Pharmaceuticals with a target price of Rs 700 per share in its research report dated September 28, 2015.

Angel Broking neutral on Alembic Pharmaceuticals

Angel Broking has maintained a neutral rating on Alembic Pharmaceuticals, in its February 05, 2015 research report.

Angel Broking neutral on Alembic Pharma

Angel Broking has maintained a 'Neutral' rating on Alembic Pharmaceuticals, in its July 30, 2014 research report.

Angel Broking neutral on Alembic Pharma

Angel Broking has maintained neutral rating on Alembic Pharmaceuticals, in its April 29, 2014, research report.

Buy Alembic Pharma; target of Rs 266: Sushil Finance

Sushil Finance is bullish on Alembic Pharmaceuticals and has recommended buy rating on the stock with a taget price of Rs 266 in its January 24, 2014 research report.